Arkolith/Insider Trading/JAZZ/Form 4

Cozadd Bruce C

DirectorJazz Pharmaceuticals plc (JAZZ) · full profile →Form 4 · filed Mar 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2026Sell(S)3K$186.09$588K409K
Mar 3, 2026Sell(S)3K$186.73$487K406K
Mar 3, 2026Sell(S)233$187.84$44K406K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193210-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML